Product Information
PAXLOVID 300-100 MG DOSE PACK is a brand product labeled by Pfizer Inc., priced at $49.2332 per EA under NDC 00069504530. Its NADAC has been published 45 times since Aug 20, 2025.
Manufacturer
Pfizer Inc.NDC
00069504530
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA217188On Market Since
7/9/2025
Price Statistics
The NADAC for PAXLOVID 300-100 MG DOSE PACK has been published 45 times since Aug 20, 2025, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.2332 per EA |
|---|---|
| All-time high | $49.2992 (May 13, 2026) |
| All-time low | $47.8414 (Nov 19, 2025) |
| 52-week high | $49.2992 |
| 52-week low | $47.8414 |
| Median price | $49.2398 |
| Average price | $48.6771 |
| Largest weekly change | +3.0% (Dec 31, 2025) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAXLOVID 300-100 MG DOSE PACK?
The current National Average Drug Acquisition Cost (NADAC) for PAXLOVID 300-100 MG DOSE PACK, manufactured by Pfizer Inc., is $49.2332 per EA (NDC 00069504530), effective Jun 24, 2026.
How has the price of PAXLOVID 300-100 MG DOSE PACK changed over time?
Over the history we have for it, the NADAC for PAXLOVID 300-100 MG DOSE PACK has risen 2.9%. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for PAXLOVID 300-100 MG DOSE PACK?
Since Aug 20, 2025, the NADAC for PAXLOVID 300-100 MG DOSE PACK has ranged from a low of $47.8414 (Nov 19, 2025) to a high of $49.2992 (May 13, 2026), with a median of $49.2398 per EA.
Are there cheaper alternatives to PAXLOVID 300-100 MG DOSE PACK?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PAXLOVID 300-100 MG DOSE PACK, but none are currently priced below it.
Who manufactures PAXLOVID 300-100 MG DOSE PACK?
PAXLOVID 300-100 MG DOSE PACK (NDC 00069504530) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification